Clinical trial
A Phase 1, Open-Label Study Evaluating the Pharmacokinetics of N91115 in Cystic Fibrosis Patients
NCT02227888 is registered in ClinicalTrials.gov with Nivalis Therapeutics, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 1, Open-Label Study Evaluating the Pharmacokinetics of N91115 in Cystic Fibrosis Patients
- Lead sponsor
- Nivalis Therapeutics, Inc.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- October 31, 2014
- Completion date
- January 31, 2015
- Enrollment
- 6 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.